Document is current
Any future updates will be listed below
-
Authors
Yiu, Hei Hang Edmund
Chow, Ling Hin
Au, Cheri Cheuk Lam
Deng, Eunice Kehui
Zhao, Zimeng
Wei, Yue
Lee, Kyung Jin
Huang, Caige
Yang, Yu
Kang, Wei
Petrou, Stavros
Madan, Jason
Chan, Esther W.
-
Funding
Funding for this research was provided by:
University Research Committee, University of Hong Kong (2202100824)
- License Information
-
More Information
Article History
Received: 18 March 2025
Accepted: 9 September 2025
First Online: 23 October 2025
Declarations
:
: This study was approved by the Institutional Review Board of the University of Hong Kong/Hospital Authority Hong Kong West Cluster (UW 23–204); Approval date: 31 March 2023. All participants provided informed consent to participate in this study.
: HHEY reported receiving research grants from the Health Bureau of the Government of the Hong Kong SAR (HMRF) and Viatris, outside the submitted work. EWC has received grants from the National Natural Science Foundation of China; grants from Research Grants Council (RGC, HKSAR), Research Fund Secretariat of the Health Bureau (Health and Medical Research Fund [HMRF], HKSAR), National Health and Medical Research Council (Australia), Narcotics Division of the Security Bureau of HKSAR, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Eisai, Janssen, Pfizer, Takeda, and Novartis; and honorarium from Pfizer, Novartis, and the Hong Kong SAR Hospital Authority, outside the submitted work.
